Literature DB >> 18218987

Vitamin K epoxide reductase complex subunit 1 (VKORC1) polymorphism and aortic calcification: the Rotterdam Study.

M Teichert1, L E Visser, R H N van Schaik, A Hofman, A G Uitterlinden, P A G M De Smet, J C M Witteman, B H Ch Stricker.   

Abstract

OBJECTIVE: Besides effects on hemostasis, vitamin K-dependent proteins play a role in bone mineralization and arterial calcification. We investigated the association between the VKORC1 1173C>T polymorphism and calcification of the aortic far wall in a large population-based cohort. METHODS AND
RESULTS: Aortic calcification was diagnosed by radiographic detection of calcified deposits in the abdominal aorta. In all cohort members for whom DNA was available, the C1173T SNP of VKORC1 (rs9934438) was determined. With multivariable logistic regression analysis the association between this polymorphism and the risk of aortic calcification was calculated, adjusted for potential confounders. The T allele frequency of the VKORC1 1173C>T polymorphism was 38.8%. 1185 (37.2%) persons were homozygous CC, 1529 (48,0%) were heterozygous CT and 473 (14.8%) were homozygous TT. Persons with at least one T-allele had a statistically significant 19% (95% CI 2 to 40%) risk increase of calcification of the aortic far wall compared to CC homozygous persons, adjusted for age and gender.
CONCLUSIONS: The T-allele of the VKORC1 1173C>T polymorphism was associated with a significantly higher risk of aortic calcification in Whites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218987     DOI: 10.1161/ATVBAHA.107.159913

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort.

Authors:  Conall M O'Seaghdha; Shih-Jen Hwang; Rachel Holden; Sarah L Booth; Caroline S Fox
Journal:  Am J Nephrol       Date:  2012-06-20       Impact factor: 3.754

2.  miR-133a regulates vitamin K 2,3-epoxide reductase complex subunit 1 (VKORC1), a key protein in the vitamin K cycle.

Authors:  Virginia Pérez-Andreu; Raúl Teruel; Javier Corral; Vanessa Roldán; Nuria García-Barberá; Salam Salloum-Asfar; María José Gómez-Lechón; Stephane Bourgeois; Panos Deloukas; Mia Wadelius; Vicente Vicente; Rocío González-Conejero; Constantino Martínez
Journal:  Mol Med       Date:  2013-01-22       Impact factor: 6.354

Review 3.  Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.

Authors:  Frank Rutsch; Yvonne Nitschke; Robert Terkeltaub
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

Review 4.  Transplantation of Exercise-Induced Extracellular Vesicles as a Promising Therapeutic Approach in Ischemic Stroke.

Authors:  Parsa Alehossein; Maryam Taheri; Pargol Tayefeh Ghahremani; Duaa Dakhlallah; Candice M Brown; Tauheed Ishrat; Sanaz Nasoohi
Journal:  Transl Stroke Res       Date:  2022-05-21       Impact factor: 6.829

5.  VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification.

Authors:  Yibo Wang; Jinxing Chen; Yu Zhang; Lv Bin; Kai Sun; Weifeng Yu; Jibin Liu; Channa Zhang; Haiqing Shen; Zhihui Hou; Fangfang Yu; Rutai Hui
Journal:  Hum Genet       Date:  2012-08-23       Impact factor: 4.132

6.  Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement.

Authors:  Danxin Wang; Huizi Chen; Kathryn M Momary; Larisa H Cavallari; Julie A Johnson; Wolfgang Sadée
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

7.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

8.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

9.  Association of functional VKORC1 promoter polymorphism with occurrence and clinical aspects of ischemic stroke in a Greek population.

Authors:  Georgia Ragia; Stella Marousi; John Ellul; Vangelis G Manolopoulos; Anna Tavridou
Journal:  Dis Markers       Date:  2013-10-31       Impact factor: 3.434

10.  Relationship between VKORC1 single nucleotide polymorphism 1173C>T, bone mineral density & carotid intima-media thickness.

Authors:  Daniela Fodor; Cosmina Bondor; Adriana Albu; Radu Popp; Ioan Victor Pop; Laura Poanta
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.